Φορτώνει......
Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment
Type 1 insulin like growth factor receptor (IGF-1R) targeted therapies showed compelling pre-clinical evidence; however, to date, this has failed to translate into patient benefit in Phase 2/3 trials in unselected patients. This was further complicated by the toxicity, including hyperglycemia, which...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Front Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Frontiers Media S.A.
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4495315/ https://ncbi.nlm.nih.gov/pubmed/26217584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00142 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|